P002 ADALIMUMAB MAINTAINS LONG-TERM REMISSION IN CROHN'S DISEASE THROUGH 2 YEARS

Autor:	R. Panaccione, G. D'Haens, J-F Colombel, Paul F. Pollack, William J. Sandborn, K.G. Lomax, R. Wong, J. Li, Paul Rutgeerts
Rok vydání:	2008
Předmět:	Pediatrics medicine.medical_specialty Crohn's disease business.industry Adalimumab medicine Long term remission business medicine.disease medicine.drug
Zdroj:	Journal of Crohn's and Colitis Supplements. 2:5
ISSN:	1873-9954
DOI:	10.1016/s1873-9954(08)70013-2
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::b3a3bc499dfe98eb2c9afdc03b24eaaa https://doi.org/10.1016/s1873-9954(08)70013-2 Zobrazit plný text záznamu